1 Stock Down 43% to Buy and Hold for 10 Years
The pandemic has receded substantially, and with it, the need for vaccines and medicines against COVID-19. That's not to say we no longer need them -- just a lot less so than we did in the earlier years of the outbreak.
Biotech giant (NASDAQ: MRNA) rose to prominence and made a lot of money thanks to its marketing of one of the leading COVID-19 vaccines, but last year, the company's shares dropped like a rock along with its revenue and earnings. Still, there is a lot to like about Moderna's business.
Let's consider why it might still be worth buying and holding the company's shares for the next decade.
Source Fool.com
Moderna Inc. Stock
We see a rather positive sentiment for Moderna Inc. with 20 Buy predictions and 2 Sell predictions.
With a target price of 134 € there is a hugely positive potential of 93.87% for Moderna Inc. compared to the current price of 69.12 €.